Nasdaq Staff Issues Delisting Determination as Atlantic American's Filing Delays Mount
AAME sits 50% above its 52-week low of $1.032 on light trading volume (0.2× avg).
Summary
Nasdaq staff has issued a delisting determination against Atlantic American, the expected next step after the company fell behind on its periodic reports. The company had already been flagged: an August 26 8-K said Nasdaq added the Q2 2026 Form 10-Q to its delinquency notice with a September 4 deadline, and an August 5 8-K disclosed a credit-agreement amendment extending the deadline for overdue financials to October. The overdue FY2025 10-K finally landed October 16, showing $6.0 million of net income mostly from non-cash investment gains, but that same day the company disclosed an April 2026 AM Best downgrade of its insurance subsidiary that breached its Truist credit terms. A delisting determination on a micro-cap insurer with a breached credit covenant is serious — it threatens listing status and adds pressure from lenders. The company can still appeal to a Nasdaq hearings panel, which would stay any suspension pending review; watch for that appeal and for the Q2 10-Q, still outstanding.
At the time of this announcement, AAME was trading at $1.55 on NASDAQ in the Finance sector, with a market capitalization of approximately $32.2M. The 52-week trading range was $1.03 to $3.24. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.